eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cystic fibrosis |
| Comorbidity | C0267963|exocrine pancreatic insufficiency |
| Sentences | 7 |
| PubMedID- 21086085 | exocrine pancreatic insufficiency (epi) is associated with conditions including cystic fibrosis (cf), chronic pancreatitis (cp), and pancreatic surgery (ps). |
| PubMedID- 21632288 | Background: pancreatic enzyme replacement therapy (pert) is critical for correction of exocrine pancreatic insufficiency (epi) in patients with cystic fibrosis (cf). |
| PubMedID- 25066363 | Safety and efficacy of creon(r) micro in children with exocrine pancreatic insufficiency due to cystic fibrosis. |
| PubMedID- 20171415 | Background: pancreatic enzyme replacement therapy (pert) is essential for maintaining adequate nutrition in children with exocrine pancreatic insufficiency (epi) due to cystic fibrosis (cf). |
| PubMedID- 25050848 | Long-term experience with zenpep in infants with exocrine pancreatic insufficiency associated with cystic fibrosis. |
| PubMedID- 21342076 | Research design and methods: patients with exocrine pancreatic insufficiency due to cystic fibrosis (cf) who had previously taken high doses of pancreatic enzymes received pancreatin 40,000 capsules (creon 40,000 minimicrospheres, abbott gmbh, hanover, germany) as part of their normal treatment for up to 2 years. |
| PubMedID- 20441244 | Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (creon) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. |
Page: 1